InFocus Capital Partners

InFocus Capital Partners is a Jericho, United States-based venture capital firm founded in 2016 by Ron Weiss and Robert F. Rothman, MD. Led by these founding partners, the firm invests in early-stage life sciences companies, specializing in breakthrough and disruptive ophthalmic opportunities. They strategically unite real-world ophthalmic insights with extensive investment experience to identify, capitalize, and develop innovations within this highly specialized sector. Their approach emphasizes optimizing successful returns by backing promising early-stage companies poised for significant impact in vision care. In February 2019, InFocus Capital Partners closed its inaugural fund, deploying capital into emerging ophthalmic technology designed to address significant unmet medical needs. Its business model centers on venture capital fund raising and managing capital for investments in early-stage companies.